WeltL.G., SachsJ.R., and McManusT.J.An ion transport defect in erythrocytes from uremic patients. Trans Assoc Am Phys.1964; 77: 169.
2.
ColeC.H.Decreased ouabain-sensitive adenosine triphosphatase activity in the erythrocyte membrane of patients with chronic renal disease. Clin Sci1973; 45: 775.
3.
KramerH.J., BackerA., and KruckF.Inhibition of intestinal (Na+-K+)-ATPase in experimental uremia. Clin Chim Acta, 1974; 50: 13.
4.
MinkoffL., GaertnerG., DarabM., MercierC., and LevinM.L.Inhibition of brain sodium-potassium ATPase in uremic rats. J Lab Clin Med1972; 80: 71.
5.
ChengJ.T., KahnT., and KajiD.M.Mechanism of alteration of sodium-potassium pump of erythrocytes from patients with chronic renal failure. J Clin Invest1984; 74: 1811.
6.
IzumoH., IzumoS., DeLuiseM., and FlierJ.S.Erythrocyte Na, K pump in uremia. Acute correction of a transportion defect by hemodialysis. J Clin Invest1984; 74: 581.
7.
BrodJ., SchaefferJ., HengstenbergJ.H., KleinschmidtT.G.Investigations on the Na+, K+-pump in erythrocytes of patients with renal hypertension. Clin Sci1984; 66: 351.
8.
KramerH.J., GospodinovD., and KruckF.Functional and metabolic studies on red blood cell sodium transport in uremia. Nephron1976; 16: 344.
9.
SwaminathanR., CleggG., CumberbatchM., ZareianZ., and McKennaF.Erythrocyte sodium transport in chronic renal failure. Clin Sci1982; 62: 489.
10.
VillamilM.F., RettoriV., and KleemanC.R.Sodium transport by red blood cells in uremia. J Lab Clin Med1968; 72: 308.
11.
FraserC.L., SarnackiP., and ArieffA.I.Abnormal sodium transport in synaptosomes from brain of uremic rats. J Clin Invest1985; 75: 2014
12.
ColeC.H., BalfeJ.W., and WeltL.G.Induction of a ouabain-sensitive ATPase defect by uremic plasma. Trans Assoc Am Phys, 1968; 81: 213.
13.
GonickH.C., KramerH.J., PaulW., and LuE.Circulating inhibitor of sodium-potassium-activated adenosine triphosphatase after expansion of extracellular fluid volume in rats. Clin Sci Mol Med1977; 53: 329.
14.
GruberK.A., WhitakerJ.M., and BuckalewV.M.Jr.. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature1980; 287.
15.
HaddyF.J., PamnaniM.B., and CloughD.L.Humoral factors and the sodium-potassium pump in volume-expanded hypertension. Life Sci1979; 24: 2105.
16.
RahmanM., PrimeraM.I., GibsonT.P., and QuintanillaA.P.Effect of salt intake on Na+, K+-ATPase activity and cation transport in the red cell. Kidney Int1983; 23: 175.
17.
RahmanM., KohH., WefferM.I., del GrecoF., and QuintanillaA.P.Na, K-ATPase and cation content in the erythrocyte in essential hypertension. J Lab Clin Med1986; 107: 337.
18.
QuintanillaA.P., FinnM., WefferM.I., and del GrecoF.Effect of treatment with hydrochlorothiazide on the red cell Na, K-ATPase in hypertensive men. J Lab Clin Med (in press).
19.
HaberE., and HaupertG.T.Jr.. The search for a hypothalamic Na+, K+-ATPase inhibitor. Hypertension, 1987; 9: 315.
20.
CarilliC.T., BerneM., CantleyL.C., and HaupertG.T.Jr.. Hypothalamic factor inhibits the (Na, K)ATPase from the extracellular surface: Mechanism of inhibition. J Biol Chem1985; 260: 1027.
21.
KellyR.A., O'HaraD.S., MitchW.E., and SmithT.W.Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids. J Biol Chem1986; 261: 11704.
22.
TamuraM., KuwanoH., KinoshitaT., and InagamiT.Identification of linoleic and oleic acids as endogenous Na+, K+-ATPase inhibitors from acute volume-expanded hog plasma. J Biol Chem1985; 260: 9672.
23.
WeltL.G., SmithE.K.M., DunnM.J.Membrane transport defect: the sick cell. Trans Assoc Am Phys1967; 30: 217.
24.
QuarelloF., BoeroR., GuarenaC.Acute effects of hemodialysis on erythrocyte sodium fluxes in uremic patients. Nephron1985; 41: 22.
